Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

34 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,484,395 shares of 16,869,505 outstanding shares and own 21% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1,625,678 shares), Blue Owl Capital Holdings LP (554,250 shares), Hudson Bay Capital Management LP (331,670 shares), Aisling Capital Management LP (325,370 shares), VANGUARD GROUP INC (243,122 shares), LPL Financial LLC (79,730 shares), GEODE CAPITAL MANAGEMENT, LLC (75,680 shares), NORTHERN TRUST CORP (54,156 shares), RENAISSANCE TECHNOLOGIES LLC (40,050 shares), and STATE STREET CORP (20,948 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.